Akbaba Gulhan, Berker Dilek, Isık Serhat, Tuna Mazhar Muslum, Koparal Suha, Vural Murat, Yılmaz Fatma Meric, Topcuoglu Canan, Guler Serdar
Department of Internal Medicine, Endocrinology and Metabolism, Mugla Sıtkı Kocman University School of Medicine, Mugla, Turkey.
Clinics of Endocrinology and Diseases of Metabolism, Ankara Numune Education and Research Hospital, Ankara, Turkey.
Wien Klin Wochenschr. 2016 Aug;128(15-16):579-85. doi: 10.1007/s00508-015-0865-9. Epub 2015 Sep 22.
Subclinical hypothyroidism (SH) occurs when serum thyroid stimulating hormone (TSH) concentrations are raised and serum thyroid hormone concentrations are normal. The effect of SH on the proinflammatory adipose cytokine releasing visceral adipose tissue (VAT) is not clear. The aim of this study is to identify the difference between the pre and posttreatment levels of VAT, leptin, and resistin in SH patients.
There were 51 SH patients and 43 age- and gender-matched healthy subjects included in the study. Thyroid functions, biochemical tests, leptin, resistin, and visceral and subcutaneous fat measurements were made. The measurements were repeated in the SH group in the third month following L-thyroxin treatment.
Initially, high sensitivity C-reactive protein, carotid artery intima-media thickness (mm), leptin, and resistin levels were significantly higher in the SH group compared to the controls, while the other parameters were similar. While no correlation was observed between TSH levels and adipokines, a positive correlation was detected between waist circumference and leptin levels (r = 0.549, p < 0.01). Visceral adipose tissue was positively correlated to age, waist circumference, and leptin levels, but negatively correlated to free thyroxin (T4) levels (r = 0.419, p = 0.009; r = 0.794, p < 0.01; r = 0.515, p < 0.01 and r = - 0.416, p = 0.009, respectively). A significant decrease was observed in VAT volume, leptin, and resistin levels of SH patients following levothyroxine treatment. Conclusion The reduced VAT volume, leptin, and resistin levels in SH patients following treatment may support the idea that TSH affects adipose tissue functions.
亚临床甲状腺功能减退症(SH)是指血清促甲状腺激素(TSH)浓度升高而血清甲状腺激素浓度正常的情况。SH对促炎脂肪细胞因子释放内脏脂肪组织(VAT)的影响尚不清楚。本研究的目的是确定SH患者治疗前后VAT、瘦素和抵抗素水平的差异。
本研究纳入了51例SH患者和43例年龄及性别匹配的健康受试者。进行了甲状腺功能、生化检查、瘦素、抵抗素以及内脏和皮下脂肪测量。SH组在左甲状腺素治疗后的第三个月重复进行这些测量。
最初,与对照组相比,SH组的高敏C反应蛋白、颈动脉内膜中层厚度(mm)、瘦素和抵抗素水平显著更高,而其他参数相似。虽然未观察到TSH水平与脂肪因子之间的相关性,但检测到腰围与瘦素水平之间存在正相关(r = 0.549,p < 0.01)。内脏脂肪组织与年龄、腰围和瘦素水平呈正相关,但与游离甲状腺素(T4)水平呈负相关(分别为r = 0.419,p = 0.009;r = 0.794,p < 0.01;r = 0.515,p < 0.01和r = -0.416,p = 0.009)。左甲状腺素治疗后,SH患者的VAT体积、瘦素和抵抗素水平显著降低。结论SH患者治疗后VAT体积、瘦素和抵抗素水平降低可能支持TSH影响脂肪组织功能这一观点。